I agree that the share price is too low.
Hitting less than $11.00 yesterday shocked me. I invested another 20K at $12.00, thinking that was the bottom....
However, I believe that the final financial reports will be out well before the end of February and the share buy back will be back in place immediately after that.
At any time the FDA final approval for the PMS end points will be announced and PMS Phase 3 trial will be a goer.
At any time the additional undisclosed disorders being targeted will be announced.
All very positive news on top of the positive news we already have, IMHO.
Till then - players above my pay grade will continue to jostle for positions.....
I agree that the share price is too low. Hitting less than...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.63 |
Change
-0.070(0.42%) |
Mkt cap ! $2.095B | |||
| Open | High | Low | Value | Volume |
| $16.68 | $16.86 | $16.51 | $4.012M | 240.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 982 | $16.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.66 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |